Gender-based treatment outcomes in diabetic hypertension

Journal of Postgraduate Medicine

Volumn 54, Issue 4, 2008, Pages 252-258

  Damanhori, A H H ^a   Al Khaja, K A J ^a   Sequeira, R ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Blood pressure control; Cardiovascular preventive therapy; Cardiovascular risk factors; Gender based treatment disparities; Glycemic control; Primary care in developing countries

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; INSULIN; LISINOPRIL; METFORMIN; METHYLDOPA; NIFEDIPINE; PERINDOPRIL; PROPRANOLOL; RESERPINE PLUS DIHYDRALAZINE PLUS CLOPAMIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETIC HYPERTENSION; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MONOTHERAPY; PRESCRIPTION; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BAHRAIN; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG PRESCRIPTIONS; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 55549126484     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.41433     Document Type: Article

References (46)

1. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombisis. JAMA 2006;295:180-9.
2. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother R, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206.
3. Graham I, Atar D, Borch-Johnson K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (onsistent by representatives of nine societies and invited experts). Eur J Cardiovasc Prev Rehabil 2007;14:E1-40.
4. nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995.
5. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
6. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 1998;351:1755-62.
7. Fuller J, Stevens LK, Chaturvedi N, Holloway JF. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev 2007;4:CD002188.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-72.
9. Working party of the International Federation (European Region). Hypertension in people with type 2 diabetes: Knowledge-based diabetes-specific guidelines. Diabetes Med 2003;20:972-87.
10. European Society of Hypertension - European Society of Cardiology Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
11. Whitworth JA; World Health Organization, International Society of Hypertension Working Group. World Health Organization (WHO), International Society of Hypertension (ISH) Statement on management of hypertension. J Hypertens 2003;21:1983-92.
12. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society Guidelines. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
13. Clowell JA; American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 2003;26:S87-8.
14. Antiplatelet Trial Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
15. Herman WH, Alexander CM, Cook JR, Boccuzzi SJ, Musliner TA, Pedersen TR, et al. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes: Finding from the Scandinavian Simvastatin Survival Study. Diabetes Care 1999;22:1771-8.
16. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC-BHF Heart Protection Study of cholesterol lowering with simvastatin 5963 people with diabetes: A randomized placebo-controlled trial. Lancet 2003;361:2005-16.
17. Juutilainen A, Lehto S, 17. Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a "coronary heart disease equivalent": An 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005;28:2901-7.
18. Oparil S, Miller AP. Gender and blood pressure. J Clin Hypertens (Greenwich) 2005;7:300-9.
19. Nilsson PM, Theobald H, Journath G, Fritz T. Gender difference in risk factor control and treatment profile in diabetes: A study in 229 Swedish primary health care centres. Scand J Prim Health Care 2004;22:27-31.
20. McFarlane SI, Castro J, Kaur J, Shin JJ, Kelling D Jr, Farag A, et al. Control of blood pressure and other cardiovascular risk factors at different practice settings: Outcomes of care provided to diabetic women compared to men. J Clin Hypertens (Greenwich) 2005;7:73-80.
21. Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Steven M, et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2008;31:69-74.
22. Gouni-Berthold I, Berthold HK, Mantzaros CS, Bohn M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008;31:1389-91.
23. World Health Organization - International Society of Hypertension. Guidelines for the management of mild hypertension. J Hypertens 1999;171:151-81.
24. Alsuwaida A. Effect of salt intake on blood pressure in diabetic hypertensive patients in Saudi Arabia. Saudi Med J 2007;28:909-12.
25. Charpentier G, Genes N, Vaur L, Amar J, Clerson P, Cambou JP, et al. Control of diabetes and cardio-vascular risk factors in patients with type 2 diabetes: A nationwide French survey. Diabetes Metab 2003;29:152-8.
26. Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: A multicentric study. Bull World Health Organ 2001;79:490-500.
27. Godley PJ, Maue SK, Farrelly EW, Frech F. The need for improved medical management of patient with concomitant hypertension and type 2 diabetes mellitus. Am J Manag Care 2005;11:206-10.
28. Kaplan NM. The deadly quartet: Upper body adiposity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989;149:1514-20.
29. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999;18:5-24.
30. Visser LE, Stricker BH, van der Velden J, Paes AH, Bakker A. Angiotensin-converting enzyme inhibitors associated cough: A population-based case control study. J Clin Epidemiol 1995;48:851-7.
31. High Blood Pressure Education Program Working Group. Report on hypertension in diabetes. Hypertension 1994;23:145-58.
32. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, et al. Influence of long-term, low-dose, diuretic-based antihypertensive therapy on glucose, lipid, uric acid and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. Arch Intern Med 1998;158:741-51.
33. ALLHAT Offices and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blockers vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2000;288:2981-97.
34. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-92.
35. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex difference in antihypertensive drug use: Determinants of choice of medication for hypertension. J Hypertens 1998;16:1545-53.
36. Klungel OH, Paes AH, de Boer A, Kuyvenhoven MM, Seidell JC, Bakker A. Sex difference in medication choice for hypertension in general practice: A study with written case simulations. Pharm World Sci 2000;22:140-6.
37. Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 2004;292:2849-59.
38. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study (UKPDS). Diabetes Care 2003;36:S28-32.
39. Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/diabetes/ faqs.htm. [last accessed 2006 Aug 30].
40. Uncontrolled diabetes. Science Writer's Guide to Uncontrolled Diabetes. Addressing the new diabetes epidemic: Uncontrolled diabetes. Available from: http://www.nyas.org/ebrief/diabetes/ resources.pdf. [last accessed on 2006 Apr 29].
41. Lebovitz HE. Oral therapies for diabetic hyperglycemia. Endocrionol Metab Clin North Am 2001;30:909-33.
42. Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol 1999;94:2165-70.
43. American Diabetes Association. Management of dyslipidemia in adults with diabetes (position statements). Diabetes Care 2003;26:S83-6.
44. Basile JN, Lackland DT, Basile JM, Riehle JE, Egan BM. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and non-diabetic patients with hypertension. J Clin Hypertens (Greenwich) 2004;6:18-25.
45. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005;28:514-20.
46. Gåfvels C, Wändell PE. Coping strategies in men and women with type 2 diabetes in Swedish primary care. Diabetes Res Clin Pract 2006;71:280-9.